The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review

M Connock; A Burls; E Frew; A Fry-Smith; A Juarez-Garcia; C McCabe; A Wailoo; K Abrams; N Cooper; A Sutton; A O'Hagan; D Moore

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review

M Connock, A Burls, E Frew, A Fry-Smith, A Juarez-Garcia, C McCabe, A Wailoo, K Abrams, N Cooper, A Sutton, A O'Hagan, D Moore

Research output: Contribution to journal › Article › peer-review

74 Citations (Scopus)

Abstract

The aim of this review is to determine the clinical effectiveness and cost-effectiveness of enzyme replacement therapy (ERT) in the treatment of symptomatic Gaucher's disease.

Original language	English
Pages (from-to)	iii-iv, ix-136
Journal	Health Technology Assessment
Volume	10
Issue number	24
Publication status	Published - Jul 2006

Keywords

Cost-Benefit Analysis
Gaucher Disease
Glucosylceramidase
Great Britain
Humans
State Medicine
Treatment Outcome

Cite this

@article{44fc658f59e34e308644362f9ecc4858,

title = "The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review",

abstract = "The aim of this review is to determine the clinical effectiveness and cost-effectiveness of enzyme replacement therapy (ERT) in the treatment of symptomatic Gaucher's disease.",

keywords = "Cost-Benefit Analysis, Gaucher Disease, Glucosylceramidase, Great Britain, Humans, State Medicine, Treatment Outcome",

author = "M Connock and A Burls and E Frew and A Fry-Smith and A Juarez-Garcia and C McCabe and A Wailoo and K Abrams and N Cooper and A Sutton and A O'Hagan and D Moore",

year = "2006",

month = jul,

language = "English",

volume = "10",

pages = "iii--iv, ix--136",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "24",

}

TY - JOUR

T1 - The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease

T2 - a systematic review

AU - Connock, M

AU - Burls, A

AU - Frew, E

AU - Fry-Smith, A

AU - Juarez-Garcia, A

AU - McCabe, C

AU - Wailoo, A

AU - Abrams, K

AU - Cooper, N

AU - Sutton, A

AU - O'Hagan, A

AU - Moore, D

PY - 2006/7

Y1 - 2006/7

N2 - The aim of this review is to determine the clinical effectiveness and cost-effectiveness of enzyme replacement therapy (ERT) in the treatment of symptomatic Gaucher's disease.

AB - The aim of this review is to determine the clinical effectiveness and cost-effectiveness of enzyme replacement therapy (ERT) in the treatment of symptomatic Gaucher's disease.

KW - Cost-Benefit Analysis

KW - Gaucher Disease

KW - Glucosylceramidase

KW - Great Britain

KW - Humans

KW - State Medicine

KW - Treatment Outcome

M3 - Article

C2 - 16796930

SN - 1366-5278

VL - 10

SP - iii-iv, ix-136

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 24

ER -

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review

Abstract

Keywords

Fingerprint

Cite this